Axon Enterprise, Inc. (NASDAQ:AXON) President Joshua Isner Sells 9,000 Shares

Axon Enterprise, Inc. (NASDAQ:AXON) President Joshua Isner sold 9,000 shares of the firm’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $683.31, for a total transaction of $6,149,790.00. Following the completion of the sale, the president now owns 308,714 shares of the company’s stock, valued at $210,947,363.34. This trade represents a 2.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $728.53 on Thursday. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $732.17. The company has a 50 day simple moving average of $576.22 and a two-hundred day simple moving average of $589.48. The company has a market capitalization of $56.72 billion, a price-to-earnings ratio of 188.25, a P/E/G ratio of 5.17 and a beta of 1.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same quarter last year, the firm earned $1.15 earnings per share. The business’s revenue for the quarter was up 31.3% on a year-over-year basis. Analysts expect that Axon Enterprise, Inc. will post 5.8 EPS for the current fiscal year.

Institutional Investors Weigh In On Axon Enterprise

Institutional investors and hedge funds have recently made changes to their positions in the company. TCTC Holdings LLC increased its position in shares of Axon Enterprise by 75.0% during the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after acquiring an additional 24 shares in the last quarter. Fourth Dimension Wealth LLC bought a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $30,000. Bartlett & CO. Wealth Management LLC increased its position in shares of Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock valued at $31,000 after acquiring an additional 33 shares in the last quarter. Catalyst Capital Advisors LLC bought a new stake in Axon Enterprise in the 1st quarter worth approximately $32,000. Finally, New Wave Wealth Advisors LLC bought a new stake in Axon Enterprise in the 4th quarter worth approximately $40,000. Institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

Several analysts have commented on AXON shares. Northcoast Research lowered shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday, February 19th. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. JMP Securities restated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Barclays raised their price objective on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an “overweight” rating in a report on Friday, May 9th. Finally, The Goldman Sachs Group raised their price objective on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a “buy” rating in a report on Wednesday. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $652.73.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.